Reason: Access restricted by the author. A copy can be requested for private research and study by contacting your institution's library service. This copy cannot be republished
Cognitive Behaviour Therapy to Treat Sleep Disturbance and Fatigue Following Acquired Brain Injury
thesis
posted on 2017-04-10, 00:33authored bySylvia Nguyen
Sleep disturbance and fatigue are common phenomena following
acquired brain injury (ABI). Prevention and management of these symptoms are important targets
in rehabilitation yet there is limited empirical investigation into effective
interventions. Although local, consensus-based guidelines have been put forward, there are no
universally established, evidence-based guidelines to treat poor sleep and fatigue
following traumatic brain injury (TBI) or stroke. Sleep disturbance and fatigue are inter-related
and have bidirectional relationships with cognitive deficits, depression, anxiety and pain. Cognitive behaviour therapy (CBT) is a promising treatment given its success in treating
these symptoms in non-neurological populations. A small number of studies have
implemented CBT to treat insomnia and fatigue in ABI cohorts but further research is needed
to draw stronger conclusions regarding treatment efficacy. The primary aims of the current research were to conduct a
pilot randomised controlled trial (RCT) to 1) evaluate the effectiveness of an
adapted CBT intervention for sleep disturbance and fatigue in a TBI sample, 2)
investigate the efficacy of the same CBT intervention in a stroke sample and 3)
identify predictors of positive response to CBT for sleep in both TBI and
stroke participants. Eligible
participants (n=36) with history of mild to severe TBI or stroke with clinically
significant fatigue and/or sleep complaints completed baseline assessment and were
randomly allocated to intervention (CBT) or treatment as usual (TAU). The intervention
consisted of eight weekly therapy sessions with a neuropsychologist. CBT was delivered
according to a manualised protocol and adapted to accommodate cognitive impairments.
Participants were reassessed at two months (post-therapy) and four months from
baseline (two-month follow-up) on primary outcome measures: the Pittsburgh
Sleep Quality Index (PSQI) and the Fatigue Severity Scale (FSS). Secondary
measures assessed insomnia severity, daily fatigue levels, daytime sleepiness,
mood and quality of life. The first study with a TBI sample revealed significantly
greater improvements for CBT recipients on the primary measure of sleep quality
(PSQI) and in insomnia (Insomnia Severity Index) than TAU. While there was no
change on the primary fatigue measure (FSS), daily fatigue levels (Brief
Fatigue Inventory) were reduced following CBT. Secondary improvements were also
noted in depression (Hospital Anxiety and Depression Scale). Gains were
maintained at two-month follow-up with large treatment effects by the end of
the study. In the second study
with a stroke cohort, there was a significant reduction on the primary fatigue
measure (FSS) following CBT. Improvements in sleep quality and insomnia were
significant post-treatment but were attenuated at follow-up. CBT participants
further reported significant decline in depression and increased physical quality
of life (SF-36). Treatment gains were maintained up to two months after therapy
cessation with large effect sizes. The third study
examined characteristics of treatment responders using classification and
regression tree (CART) analyses. As a combined ABI sample, better memory,
younger age and higher baseline depression were associated with greater
improvements in sleep quality following CBT.
This research
illustrates the feasibility of delivering adapted CBT to treat sleep disturbance
and fatigue following ABI, but larger RCTs are required to extend and replicate
these pilot findings.